top of page

Accelerating Innovation in mRNA Therapeutics

McGill University's core facility dedicated to advancing mRNA research and therapeutic development through biomanufacturing excellence.

Welcome to
McGill mRNA Therapeutics Platform

The platform is a collaborative research and biomanufacturing hub dedicated to accelerating the discovery, development, and translation of mRNA-based therapeutics. We provide access to affordable, high-quality mRNA production, formulation, bioprocessing expertise, and specialized technologies that help researchers move from innovative concepts toward therapeutic applications.

​

By connecting academia, healthcare, and industry, we empower researchers and innovators across Quebec and Canada to develop the next generation of mRNA medicines through collaboration, training, and accessible biomanufacturing capabilities.

End-to-End mRNA Development
 

Integrated workflows spanning mRNA sequence design, in vitro transcription, purification, quality control, and LNP formulation under one roof.

Automated & Scalable Bioproduction

Automated mRNA production and purification workflows that enhance reproducibility and efficiency while supporting scalable, high-throughput preclinical research.

Collaborative Partners

A collaborative network connecting academic researchers, clinicians, and industry partners to accelerate RNA therapeutic development.

bottom of page